PharmaBioSource provided exclusive consulting services to Lubrizol on the divestment of its contract development and manufacturing subsidiary, Particle Sciences, to Agno Pharma.

• Service: Consulting
• Sector: Pharmaceuticals
• Sub-sector: Sterile Injectables and Other Drug Product Formulation Development CDMO
• Engagement Type: Sell Side

PharmaBioSource assisted Lubrizol to divest Particle Sciences, a Bethlehem, PA-based specialty drug product formulation development business and its 50,000 SF laboratory and clinical manufacturing facility which also housed a brand new sterile injectable filling suite. Agno Pharma acquired Particle Sciences in a fast-paced transaction process of only three months.

PharmaBioSource’s services included buyer target identification, creation of the confidential information memorandum (CIM), marketing, data room and due diligence support.

Press Release